CH565817A5 - - Google Patents

Info

Publication number
CH565817A5
CH565817A5 CH1543471A CH1543471A CH565817A5 CH 565817 A5 CH565817 A5 CH 565817A5 CH 1543471 A CH1543471 A CH 1543471A CH 1543471 A CH1543471 A CH 1543471A CH 565817 A5 CH565817 A5 CH 565817A5
Authority
CH
Switzerland
Application number
CH1543471A
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of CH565817A5 publication Critical patent/CH565817A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/0085Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0094Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing nitrile radicals, including thiocyanide radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/008Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
    • C07J7/009Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by only one oxygen atom doubly bound
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CH1543471A 1970-10-27 1971-10-22 CH565817A5 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702052634 DE2052634A1 (de) 1970-10-27 1970-10-27 Neue durch einen Steroidrest substi tuierte Derivate der Acrylsäure und Ver fahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
CH565817A5 true CH565817A5 (en:Method) 1975-08-29

Family

ID=5786264

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1543471A CH565817A5 (en:Method) 1970-10-27 1971-10-22

Country Status (12)

Country Link
US (1) US3752803A (en:Method)
AT (1) AT306255B (en:Method)
AU (1) AU462855B2 (en:Method)
BE (1) BE774509A (en:Method)
CH (1) CH565817A5 (en:Method)
DE (1) DE2052634A1 (en:Method)
DK (1) DK130309B (en:Method)
ES (1) ES395530A1 (en:Method)
FR (1) FR2111864B1 (en:Method)
GB (1) GB1357394A (en:Method)
NL (1) NL7114776A (en:Method)
SE (1) SE372528B (en:Method)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2245726B2 (de) * 1972-09-18 1979-01-18 Dr. Karl Thomae Gmbh, 7950 Biberach -androstan-17 ß -yl)-acrylnitril-3",4"-carbonat, Verfahren zu seiner Herstellung und diese enthaltende Arzneimittel
US3949074A (en) * 1973-09-17 1976-04-06 Boehringer Ingelheim Gmbh Cardiotonic pharmaceutical compositions containing a cardiac glycoside and method of use
US4229441A (en) * 1978-12-01 1980-10-21 Merck & Co., Inc. Immunologic adjuvant
US5144017A (en) * 1988-07-13 1992-09-01 University Of Manitoba Compounds that bind to digitalis receptor

Also Published As

Publication number Publication date
NL7114776A (en:Method) 1972-05-02
GB1357394A (en) 1974-06-19
AU3494071A (en) 1973-05-03
DK130309B (da) 1975-02-03
FR2111864B1 (en:Method) 1975-10-10
SE372528B (en:Method) 1974-12-23
DK130309C (en:Method) 1975-06-30
FR2111864A1 (en:Method) 1972-06-09
DE2052634A1 (de) 1972-05-04
ES395530A1 (es) 1973-12-01
US3752803A (en) 1973-08-14
AT306255B (de) 1973-04-10
BE774509A (fr) 1972-04-26
AU462855B2 (en) 1975-07-10

Similar Documents

Publication Publication Date Title
ATA96471A (en:Method)
AU1146470A (en:Method)
AU2044470A (en:Method)
AU1473870A (en:Method)
AU1326870A (en:Method)
AU2130570A (en:Method)
AU2085370A (en:Method)
AU2017870A (en:Method)
AU1833270A (en:Method)
AU1716970A (en:Method)
AU1517670A (en:Method)
AU1336970A (en:Method)
AU1591370A (en:Method)
AU1841070A (en:Method)
AU2144270A (en:Method)
AU2131570A (en:Method)
AU2130770A (en:Method)
AU1328670A (en:Method)
AU1277070A (en:Method)
AU1343870A (en:Method)
ATA672271A (en:Method)
AU2119370A (en:Method)
AU1247570A (en:Method)
AU1581370A (en:Method)
AU1235770A (en:Method)

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased